Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-NOS PET/CT for Neuroinflammation in Parkinson's Disease
NCT04062526Phase 1Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Aug 2019
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 18F-NOS in Parkinson's disease (PD) (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Characterize the uptake of [18F]NOS at 3 years. Started Aug 2019; status: active, not recruiting.
02
Drugs
18F-NOS
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04062526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04062526.